Probiotic Treatment of Orthodontic Patients

NCT06751979 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-12-30

No results posted yet for this study

Summary

The purpose of this study is to examine the effect of treatment with a lozenge containing the probiotic strain S. salivarius M18 on the formation, composition and virulence of dental plaque and in healthy orthodontic patients, compared to placebo control.

Conditions

  • Dental Plaque
  • Dental Caries

Interventions

DIETARY_SUPPLEMENT

Probiotic treatment

Daily intake of a lozenge containing the probiotic strain S. salivarius M18.

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Bluestone Pharma

    collaborator UNKNOWN
  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-02
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06751979 on ClinicalTrials.gov